[2P] Neurodegenerative Disorders

[2P-218] Generation of a human induced pluripotent stem cell line derived from a Parkinson's disease patient demonstrating SNCA duplication

*Hidefumi Suzuki^1,2,3, Naohiro Egawa^1,2,3, Takayuki Kondo^2,3,4, Ryosuke Takahashi¹, Haruhisa Inoue^2,3,4 (1.Dept Neurol, Kyoto Univ, Kyoto, Japan, 2.iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan, 3.Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan, 4.Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan)